Proximagen Company

Proximagen is a neuroscience research company developing drugs for neurodegenerative disorders, including Parkinson’s and Alzheimers.


Investors

Founded Date: 2003
Last Funding Type: Venture - Series Unknown
Headquarters: London, England, United Kingdom
Investors Number: 1
Technology: Others
Employee Number: 11-50
Industry: PharmTech
Estimated Revenue: $1M to $10M
Number Of Exists: Venture - Series Unknown
Funding Status: N/A
Investor Type: Company
Investment Stage: N/A
Total Funding: $96.5M